leading glp-1 treatments for diabetes 2025 Impact: How GLP-1s Are Changing the Treatment Paradigm The Landscape Of GLP-1 Receptor

Huang, J

Individuals were also ineligible if they had any contraindications to study treatment or if, in the opinion of the investigator, they had any other medical condition, clinically significant laboratory result or electrocardiogram findings that may compromise safety or compliance, preclude the participant from successful study completion or interfere with interpretation of results

Metabolism 2021;118:154728.ArticlePubMed 77

Abstract Traditionally, Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), a pivotal class of drug, mimics the actions of endogenous Glucagon-like peptide-1, which have been found to be remarkable in the treatment of type 2 diabetes alongside other comorbidities

It wont wipe out a bad diet

Not suitable for those monitoring blood sugar or trying to avoid glucose spikes